Brind.

Merck acquired Verona Pharma for $10 billion on August 5, 2025.

11 reports, 6 independent Updated Jul 9
Gone quiet Reached 4 outlets in its first 24 hours
Reports
11
Developments
4
Repetition
64%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 6 independent outlets

Merck acquired Verona Pharma for $10 billion on August 5, 2025.

Who's involved

What this event is mainly about
Merck KGaAVerona Pharma

How it developed

Newest first. Tap a step to see who reported it.
  1. Merck completed the acquisition of Verona Pharma for $10 billion.1 source
  2. Jim Cramer discussed the Merck acquisition of Verona Pharma.1 source
  3. Merck's commercial footprint accelerates Ohtuvayre uptake following the acquisition.1 source
  4. The acquisition enhances Merck's cardio-pulmonary pipeline and was subject to UK High Court jurisdiction.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • dailypolitical.com
  • manilatimes.net
  • Pharma VoiceLet’s make a deal? Big Pharma execs express varying views on their M&A future This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily Pharm
  • Insider MonkeyJefferies Raises Merck (MRK) Price Target, Maintains Buy Rating Merck & Company, Inc. (NYSE:MRK) is one of the high-margin pharma stocks to buy now. Jefferies has raised its price target on Merck & C
  • Insider MonkeyVerona Pharma plc (VRNA) Is Unlikely To Face Antitrust Action For Merck Deal, Says Jim Cramer We recently published Jim Cramer Analyzed These 9 Stocks As He Said Tariffs Are Better Than CIA Coups. Ve
  • BioPharma DiveWith Verona deal, Merck wagers on strength of lung drug’s patents This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive
  • Insider MonkeyVerona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck Verona Pharma plc (NASDAQ:VRNA) is one of the 10 Stocks Going Wild. Verona Pharma surged by 20.62 percent on Wednesday to e
  • Pharmaceutical TechnologyMerck agrees to acquire Verona Pharma for $10bn Merck has agreed to acquire biopharmaceutical company Verona Pharma in a deal valued at $10bn. The acquisition will be made by the subsidiary of Merck,
  • Unknown outlet
  • Unknown outlet
  • Unknown outlet